Banque Pictet & Cie Sa Iveric Bio, Inc. Transaction History

Banque Pictet & Cie Sa

  • $13.1 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$9.12 - $18.9 $117,173 - $242,827
-12,848 Reduced 8.79%
133,317 $1.28 Million
Q1 2022

May 04, 2022
SELL
$12.15 - $16.83 $152,919 - $211,822
-12,586 Reduced 7.93%
146,165 $2.46 Million
Q4 2021

Feb 02, 2022
BUY
$13.83 - $18.78 $2.2 Million - $2.98 Million
158,751 New
158,751 $2.65 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email